Mark McClellan directs the Duke-Margolis Center for Health Policy, is a former FDA commissioner and CMS administrator, and is an independent member of the Board of Directors of Johnson & Johnson.
Mark McClellan
-
Monday 30 August 2021
The Arms Race
Our six point plan for Biden’s Covid summit
The president is close to announcing a special gathering of world leaders to draw up a strategy to end the pandemic. Here are the main issues they must tackle